TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16351674

Group type: EXPERIMENTAL
Intervention: Intravenous metoclopramide (2 cc of 10 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (2 cc)
Number of subjects: 100
Study: 12851665

Group type: EXPERIMENTAL
Intervention: Enhanced Pharmaceutical Care (EC)
Number of subjects: 631
Study: 10349117

Group type: EXPERIMENTAL
Intervention: Intravenous diphenhydramine (DPH)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Oral diphenhydramine (DPH)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Functional score after oral DPH
Number of subjects: 7
Study: 7502136

Group type: EXPERIMENTAL
Intervention: Free-fat graft
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Gelfoam
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: No interposition membrane
Number of subjects: 156
Study: 2019162

Group type: EXPERIMENTAL
Intervention: Albuterol, 90 micrograms by inhalation four times a day
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 27
Study: 7460650

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (13 patients)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (15 patients)
Number of subjects: 28
Study: 31488225

Group type: EXPERIMENTAL
Intervention: Smaller than normal portion size
Number of subjects: 82

Group type: COMPARATOR
Intervention: Small-normal portion size
Number of subjects: 82

Group type: COMPARATOR
Intervention: Large-normal portion size
Number of subjects: 82
Study: 31337518

Group type: EXPERIMENTAL
Intervention: Preoperative peer education
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine education by a nurse
Number of subjects: 70
Study: 30280751

Group type: EXPERIMENTAL
Intervention: Microencapsulated garlic
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tomato extract
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Mixture of microencapsulated garlic and tomato extract
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 27120177

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: ABCB1 3435C>T alleles
Number of subjects: 104
Study: 25057199

Group type: EXPERIMENTAL
Intervention: Previous perceptual experience with the ambiguous visual stimulus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous stimulus presentations regardless of perception
Number of subjects: 0
Study: 21707811

Group type: EXPERIMENTAL
Intervention: Sertraline 200 mg/day
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 19224365

Group type: EXPERIMENTAL
Intervention: Evidence-based treatment (EBT) for child PTSD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: School screening in schools in New Orleans
Number of subjects: 0
Study: 17462100

Group type: EXPERIMENTAL
Intervention: EQ-5D
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: SF-36
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Summary utility measures
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: All utility measures
Number of subjects: 978
Study: 15225188

Group type: EXPERIMENTAL
Intervention: PGE(1) induced labor
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: PGE(2) induced labor
Number of subjects: 88

Group type: COMPARATOR
Intervention: Spontaneous active labor
Number of subjects: 88
Study: 12063523

Group type: EXPERIMENTAL
Intervention: Nasal glucocorticoid (fluticasone propionate aqueous nasal spray [FPANS], 200 microg/d)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combination of montelukast (10 mg/d) and antihistamine (loratadine, 10 mg/d)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg/d)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 9802705

Group type: EXPERIMENTAL
Intervention: Biodegradable controlled-release delivery system containing doxycycline hyclate (8.5% w/w)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral doxycycline (200 mg on day 0, then 100 mg/day for 7 days)
Number of subjects: 32
Study: 7702024

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (LCT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (LCT) and Medium-chain triglycerides (MCT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 14
Study: 2503294

Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC)
Number of subjects: 704

Group type: COMPARATOR
Intervention: Intrauterine device (IUD)
Number of subjects: 704
Study: 404157

Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH) 50 U i.v. followed by 2 U/min infusion for 60-90 min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no PTH)
Number of subjects: 6
Study: 31429876

Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV) for 30 minutes
Number of subjects: 1018

Group type: COMPARATOR
Intervention: T-piece ventilation for 2 hours
Number of subjects: 1018
Study: 26659730

Group type: EXPERIMENTAL
Intervention: LF rTMS (1 Hz)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HF rTMS (10 Hz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 26360645

Group type: EXPERIMENTAL
Intervention: Immediate video feedback (IVF) training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional training (control)
Number of subjects: 18
Study: 23552023

Group type: EXPERIMENTAL
Intervention: SMS drinking assessments with feedback (SA+F) for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SMS drinking assessments without feedback (SA) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 21342490

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 5699

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5699

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 5699

Group type: EXPERIMENTAL
Intervention: Country (Scotland vs Netherlands)
Number of subjects: 5699

Group type: EXPERIMENTAL
Intervention: Country (Ireland vs Netherlands)
Number of subjects: 5699

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure
Number of subjects: 5699

Group type: EXPERIMENTAL
Intervention: MMSE Score
Number of subjects: 5699

Group type: EXPERIMENTAL
Intervention: Plasma Factor VIII levels
Number of subjects: 5699
Study: 19724276

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus axitinib (Gem+A)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Gemcitabine alone
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Any dBP>90 mmHg
Number of subjects: 95
Study: 17692922

Group type: COMPARATOR
Intervention: Fluconazole (150 mg single dose)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Boric acid suppositories (600 mg daily for 14 days)
Number of subjects: 40
Study: 15155324

Group type: EXPERIMENTAL
Intervention: IV parecoxib 40 mg followed by oral valdecoxib 40 mg
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 11678385

Group type: EXPERIMENTAL
Intervention: 60% tilt experimental waveform (336 microF capacitor)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 80% tilt experimental waveform (336 microF capacitor)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard 140 microF 80% tilt biphasic waveform (two 280 microF capacitors in series)
Number of subjects: 54
Study: 9862047

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoendocrine therapy (mitozantrone and methotrexate (+/‐ mitomycin‐C) combined with tamoxifen)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Adjuvant therapy
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoendocrine therapy
Number of subjects: 309

Group type: COMPARATOR
Intervention: Neoadjuvant and adjuvant therapy
Number of subjects: 309
Study: 7832334

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg orally)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Midazolam (2 mg/70 kg intravenously)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fentanyl (50 micrograms/70 kg intravenously)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propofol (70 mg/70 kg intravenously)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (orally and intravenously)
Number of subjects: 12
Study: 2114989

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Atropine (600 micrograms)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg)
Number of subjects: 7
Study: 226565

Group type: EXPERIMENTAL
Intervention: Sotalol 320 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sotalol 960 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 12
Study: 31518936

Group type: EXPERIMENTAL
Intervention: LPG cookstove intervention
Number of subjects: 260

Group type: COMPARATOR
Intervention: 3-stone cookstove (baseline)
Number of subjects: 260
Study: 27839894

Group type: EXPERIMENTAL
Intervention: ClearGuard HD Antimicrobial Barrier Caps
Number of subjects: 2470

Group type: EXPERIMENTAL
Intervention: ClearGuard HD Antimicrobial Barrier Caps (sustained use)
Number of subjects: 2470

Group type: COMPARATOR
Intervention: Standard CVC caps
Number of subjects: 2470
Study: 25316180

Group type: EXPERIMENTAL
Intervention: Repetitive wrist extension (30 repetitions with maximal isometric contraction for 6 minutes)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Repetitive wrist extension
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 23877689

Group type: EXPERIMENTAL
Intervention: 15% paromomycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 15% paromomycin plus 0.5% gentamicin (WR 279,396)
Number of subjects: 0
Study: 21452931

Group type: EXPERIMENTAL
Intervention: Noble metal alloy-coated latex catheter
Number of subjects: 439

Group type: COMPARATOR
Intervention: Silicone catheter
Number of subjects: 439
Study: 19296248

Group type: EXPERIMENTAL
Intervention: Preventive enteral nutrition (EN) - 1000 ml Nutrison Multi Fibre (4184 kJ/L) for 3 days before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no preventive enteral nutrition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preventive enteral nutrition (EN)
Number of subjects: 0
Study: 17768771

Group type: EXPERIMENTAL
Intervention: Substance P (1.5 pmol/kg/min)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 13
Study: 15170367

Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg single dose
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg multiple doses (once monthly)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg (once monthly)
Number of subjects: 219
Study: 11213882

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 59

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 59
Study: 11798226

Group type: EXPERIMENTAL
Intervention: Evidence-based pain management guidelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research and systematic reviews
Number of subjects: 0
Study: 9301991

Group type: EXPERIMENTAL
Intervention: Clarithromycin-omeprazole dual therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Omeprazole therapy alone
Number of subjects: 22
Study: 8330823

Group type: EXPERIMENTAL
Intervention: Flupirtine
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study: 3631465

Group type: EXPERIMENTAL
Intervention: Pethidine/promethazine with fentanyl
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 20
Study: 2673883

Group type: EXPERIMENTAL
Intervention: Ethynyloestradiol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Norethisterone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined norgestrel and ethynyloestradiol
Number of subjects: 20

Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 20
Study: 31229200

Group type: EXPERIMENTAL
Intervention: Mouth-opening intervention with remote support via telephone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Active control group (no remote support)
Number of subjects: 60
Study: 28133906

Group type: EXPERIMENTAL
Intervention: Everolimus with low-exposure tacrolimus discontinued by month 4
Number of subjects: 188

Group type: COMPARATOR
Intervention: Tacrolimus-based therapy
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 188

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 188
Study: 24942409

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX) 1.4 ± 0.5 mg/kg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate (MPH) 52.4 ± 16.6 mg
Number of subjects: 102
Study: 23423753

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21914270

Group type: EXPERIMENTAL
Intervention: Protein-free calf blood extract eye gel (3 times per day for three months)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No treatment (no drug treated group)
Number of subjects: 49
Study: 19411787

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral nursing intervention (2 hr/week for 6 weeks)
Number of subjects: 71
Study: 17561724

Group type: EXPERIMENTAL
Intervention: Sartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beta-blocker
Number of subjects: 0
Study: 15084068

Group type: EXPERIMENTAL
Intervention: 11C-acetate
Number of subjects: 6

Group type: COMPARATOR
Intervention: nontumor liver tissue
Number of subjects: 6
Study: 11174292

Group type: EXPERIMENTAL
Intervention: 5% sodium thiosulfate solution spray
Number of subjects: 120

Group type: COMPARATOR
Intervention: Maalox (aluminum‐magnesium hydroxide gel)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 120
Study: 9433426

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 325

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study: 8948741

Group type: EXPERIMENTAL
Intervention: Gelatine infusion with 3.5% urea bridges during normovolemic intentional hemodilution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crystalloid infusion
Number of subjects: 0
Study: 2517008

Group type: EXPERIMENTAL
Intervention: Rilmenidine 1 mg
Number of subjects: 244

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 244
Study: 795443

Group type: EXPERIMENTAL
Intervention: Nicotinic acid analogue
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 12
Study: 31009034

Group type: EXPERIMENTAL
Intervention: Albuterol (2 actuations, 200 μg)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 484
Study: 29190720

Group type: EXPERIMENTAL
Intervention: Mediterranean/low-carbohydrate diet (MED/LC) with 28g·day-1 of walnuts + moderate intense physical activity (PA+)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF) + moderate intense physical activity (PA+)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Mediterranean/low-carbohydrate diet (MED/LC) with 28g·day-1 of walnuts + non-physical activity (PA-)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF) + non-physical activity (PA-)
Number of subjects: 277
Study: 25551626

Group type: EXPERIMENTAL
Intervention: Hippotherapy (30 minutes twice weekly for 8 consecutive weeks)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 92
Study: 24064879

Group type: EXPERIMENTAL
Intervention: 80% FIO2 intraoperatively and for 2 hours afterward
Number of subjects: 222

Group type: COMPARATOR
Intervention: 30% FIO2 during the same period
Number of subjects: 222
Study: 21954342

Group type: EXPERIMENTAL
Intervention: Telfa AMD(®)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Bactigras(®)
Number of subjects: 32
Study: 19085221

Group type: EXPERIMENTAL
Intervention: Art therapy session
Number of subjects: 79

Group type: COMPARATOR
Intervention: Videotape about art therapy
Number of subjects: 79
Study: 17045803

Group type: EXPERIMENTAL
Intervention: Concurrent motor task (carrying a tray with marbles)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Concurrent motor task (carrying a tray without marbles)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cognitive task (repeating a series of digits forwards or backwards)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Walking alone (no concurrent task)
Number of subjects: 48
Study: 15090936

Group type: EXPERIMENTAL
Intervention: Modafinil (100 mg/day for days 1-14; 100 or 200 mg/day for days 15-28)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 11
Study: 11466245

Group type: EXPERIMENTAL
Intervention: Carteolol alginate once daily
Number of subjects: 235

Group type: COMPARATOR
Intervention: Standard carteolol solution, twice daily
Number of subjects: 235
Study: 9710300

Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg, equivalent to 2 to 3 cups of coffee)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine plus tasks (behavioral stress)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tasks alone (mental stressor and psychomotor task)
Number of subjects: 0
Study: 8199744

Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapy
Number of subjects: 323

Group type: COMPARATOR
Intervention: Lidocaine prophylaxis
Number of subjects: 323
Study: 2846002

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sympathomimetics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroids (oral or parenteral)
Number of subjects: 0
Study: 30578392

Group type: EXPERIMENTAL
Intervention: Anlotinib therapy
Number of subjects: 294
Study: 28245383

Group type: EXPERIMENTAL
Intervention: Combined treatment group (hydroxyurea plus IFN-alpha)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine treatment group (hydroxyurea)
Number of subjects: 50
Study: 26854931

Group type: EXPERIMENTAL
Intervention: Personalized disease risk feedback
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Supplementary risk assessments (one family member)
Number of subjects: 497
Study: 24929889

Group type: EXPERIMENTAL
Intervention: Progestogen-only pills (POPs)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Rapid access to family planning clinic (FPC)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 168
Study: 22381428

Group type: EXPERIMENTAL
Intervention: Watchman device implantation with peri-device flow
Number of subjects: 0
Study: 19580584

Group type: EXPERIMENTAL
Intervention: MEL 308 nm once-weekly and oral vitamin E
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: MEL 308 nm once-weekly combined with khellin 4% ointment and oral vitamin E
Number of subjects: 48

Group type: COMPARATOR
Intervention: Oral vitamin E (control group)
Number of subjects: 48
Study: 17924873

Group type: EXPERIMENTAL
Intervention: 303 Algorithm group (self-titration dosing guideline)
Number of subjects: 5604

Group type: COMPARATOR
Intervention: Standard-of-care group (physician-driven adjustments)
Number of subjects: 5604

Group type: EXPERIMENTAL
Intervention: 303 Algorithm group
Number of subjects: 5604

Group type: COMPARATOR
Intervention: Standard-of-care group
Number of subjects: 5604
Study: 15356670

Group type: EXPERIMENTAL
Intervention: Active treatment (herbal formulation containing ephedrine, caffeine, and other ingredients)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 11368462

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo 5 mg
Number of subjects: 36
Study: 9529020

Group type: EXPERIMENTAL
Intervention: MAID chemotherapy (doxorubicin, dacarbazine, ifosfamide, and mesna)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: MAID chemotherapy
Number of subjects: 69
Study: 8053040

Group type: EXPERIMENTAL
Intervention: Distribution of recruitment brochures 2 weeks in advance of blood drives and provision of temporary deferral brochures during health history taking (Experimental Group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no brochures distributed)
Number of subjects: 24
Study: 2657839

Group type: EXPERIMENTAL
Intervention: Buspirone (mean dose 29.5 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Imipramine (mean dose 140 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Buspirone and Imipramine
Number of subjects: 60
Study: 30284910

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastrojejunostomy (ReY)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Billroth II gastrojejunostomy (BII)
Number of subjects: 64
Study: 28963129

Group type: EXPERIMENTAL
Intervention: Low intensity exercise (150-min intermittent)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (150-min intermittent)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High intensity exercise (150-min intermittent)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: On-court training
Number of subjects: 42
Study: 24535937

Group type: EXPERIMENTAL
Intervention: Decitabine + NY-ESO-1 vaccine + doxorubicin liposome chemotherapy
Number of subjects: 12
Study: 24345099

Group type: EXPERIMENTAL
Intervention: Radial approach
Number of subjects: 200

Group type: COMPARATOR
Intervention: Vascular closure device (femoral access)
Number of subjects: 200
Study: 20672721

Group type: EXPERIMENTAL
Intervention: At-home whitening (HW) with 10% carbamide peroxide overnight
Number of subjects: 20

Group type: COMPARATOR
Intervention: In-office whitening (OW) with 25% hydrogen peroxide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Preference and recommendation
Number of subjects: 20
Study: 18793913

Group type: EXPERIMENTAL
Intervention: Sublingual triazolam 0.25 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 15728060

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 mL of epidural saline
Number of subjects: 0
Study: 12503978

Group type: EXPERIMENTAL
Intervention: Candesartan (16 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60